Patents by Inventor Sarah Jane Dickerson

Sarah Jane Dickerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160281063
    Abstract: Methods for producing engineered induced pluripotent stem (iPS) cells are provided comprising introducing a first nucleic acid into somatic cells for integration into their genome and reprogramming the cells to produce engineered iPS cells having the nucleic acid integrated into their genome. For example, in certain aspects the cells are reprogrammed by introduction of a genetic element that expresses one or more reprogramming factor and culturing of the cells under conditions sufficient to produce reprogrammed cells.
    Type: Application
    Filed: February 23, 2016
    Publication date: September 29, 2016
    Applicant: Cellular Dynamics International, Inc.
    Inventors: Thomas J. BURKE, Michael MILLER, Michael McLACHLAN, Sarah Jane DICKERSON, Anne STROUSE
  • Publication number: 20140349397
    Abstract: Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.
    Type: Application
    Filed: May 21, 2014
    Publication date: November 27, 2014
    Applicant: CELLULAR DYNAMICS INTERNATIONAL, INC.
    Inventors: James THOMSON, Deepika RAJESH, Sarah Jane DICKERSON, Amanda MACK, Michael MILLER
  • Patent number: 8765470
    Abstract: Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: July 1, 2014
    Assignee: Cellular Dynamics International, Inc.
    Inventors: James Thomson, Deepika Rajesh, Sarah Jane Dickerson, Amanda Mack, Michael Miller
  • Publication number: 20130040302
    Abstract: Methods for producing engineered induced pluripotent stem (iPS) cells are provided comprising introducing a first nucleic acid into somatic cells for integration into their genome and reprogramming the cells to produce engineered iPS cells having the nucleic acid integrated into their genome. For example, in certain aspects the cells are reprogrammed by introduction of a genetic element that expresses one or more reprogramming factor and culturing of the cells under conditions sufficient to produce reprogrammed cells.
    Type: Application
    Filed: July 11, 2012
    Publication date: February 14, 2013
    Inventors: Thomas J. Burke, Michael Miller, Michael McLachlan, Sarah Jane Dickerson, Anne Strouse
  • Publication number: 20120058562
    Abstract: Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.
    Type: Application
    Filed: August 3, 2011
    Publication date: March 8, 2012
    Inventors: JAMES THOMSON, Deepika Rajesh, Sarah Jane Dickerson, Amanda Mack, Michael Miller